學名藥:全球市場的合作的機會

本報告提供全球35個國家裡，160家中堅學名藥製造企業調查分析，為您概述為以下內容。。

調查內容

• 企業概要
• 企業背景
• 產品
• 財務資訊
• 主要的開發趨勢
• 聯絡處資訊

調查對象企業

• 非洲
  • EIPICo(埃及)
  • Hikma Pharmaceuticals(約旦)
  • Regal Pharmaceuticals(肯亞)
  • Oman Pharmaceutical Products(阿曼)
  • Adcock Ingram(南非)
  • Cipla Medpro(南非)
  • Litha Healthcare(南非)
  • Pharma Dynamics(南非)
  • Sonke Pharmaceuticals(南非)
• 亞洲
  • Beximco Pharmaceuticals(banguradesshu)
  • Aoxing Pharmaceutical(中國)
  • Laiyang Jiangbo Pharmaceuticals(中國)
  • Rxmidas Pharmaceuticals(中國)
  • Zhejiang Huahai Pharmaceuticals(中國)
  • Alembic Pharmaceuticals(印度)
  • Alkem Laboratories(印度)
  • Bafna Pharmaceuticals(印度)
  • Bharat Serums and Vaccines(印度)
  • Biocon(印度)
  • Claris Lifesciences(印度)
  • Emcure(印度)
  • Gland Pharma(印度)
  • Glenmark Pharmaceuticals(印度)
  • Granules(印度)(印度)
  • Hetero Drugs(印度)
  • Indoco Remedies(印度)
  • Intas Pharmaceuticals(印度)
  • JB Chemicals & Pharmaceuticals(印度)
  • Jubilant Life Sciences(印度)
  • Macleods Pharmaceuticals(印度)
  • Marksans Pharma(印度)
  • Micro Labs(印度)
  • Natco Pharma(印度)
  • Orchid Chemicals & Pharmaceuticals(印度)
  • RPG Life Sciences(印度)
  • Shasun Pharmaceuticals(印度)
  • Strides Arcolab(印度)
  • Torrent Pharmaceuticals(印度)
  • Unichem Laboratories(印度)
  • Venus Remedies(印度)
  • Nichi-Iko Pharmaceutical(日本)
  • 日本Chemiphar(日本)
  • 東和藥品(日本)
  • CCM Pharmaceuticals(馬來西亞)
  • Inno Biologics(馬來西亞)
  • Pharmaniaga Berhad(馬來西亞)
  • ScinoPharm(台灣)
  • Government Pharmaceutical Organisation(並列)
  • Abdi Ibrahim(土耳其)
  • EastPharma(土耳其)
  • Mustafa Nevzat Pharmaceuticals(土耳其)
  • Nanogen Biopharmaceuticals(越南)
• 澳大利西亞
  • Alchemia(澳洲)
  • Ascent Pharmahealth(澳洲)
• 歐洲
  • BioAlliance Pharma(法國)
  • Alfred E Tiefenbacher(德國)
  • Genepharm(希臘)
  • Pharmathen(希臘)
  • Consilient Health(愛爾蘭)
  • Reliance GeneMedix(愛爾蘭)
  • ACS Dobfar(義大利)
  • Grindeks(拉脫維亞)
  • Sanitas(立陶宛)
  • Genmed Holdings(荷蘭)
  • Synthon(荷蘭)
  • Navamedic(挪威)
  • Polpharma(波蘭)
  • Hovione FarmaCiencia(葡萄牙)
  • R-Pharm(俄羅斯)
  • Laboratorios Cinfa(西班牙)
  • Bluefish Pharmaceuticals(瑞典)
  • Acino(瑞士)
  • Legacy Pharmaceuticals International(瑞士)
  • Goldshield Group(英國)
  • Kent Pharmaceuticals(英國)
  • Syntropharma(英國)
• 北美
  • AA Pharma(加拿大)
  • BioVectra(加拿大)
  • Intellipharmaceutics International(加拿大)
  • Acella Pharmaceuticals(美國)
  • Aceto(美國)
  • Akorn(美國)
  • Altaire Pharmaceuticals(美國)
  • Alvogen(美國)
  • Amerigen Pharmaceuticals(美國)
  • Amneal Pharmaceuticals(美國)
  • Amphastar Pharmaceuticals(美國)
  • Anchen Pharmaceutical(美國)
  • Antares Pharma(美國)
  • Apicore(美國)
  • APP Pharmaceuticals(美國)
  • Austarpharma(美國)
  • Avanthi(美國)
  • Banner Pharmacaps(美國)
  • Bedford Laboratories(美國)
  • Biokey(美國)
  • Boca Pharmacal(美國)
  • Breckenridge Pharmaceutical(美國)
  • Cambrex(美國)
  • Carlsbad Technology(美國)
  • Cephazone Pharma(美國)
  • Cobrek Pharmaceuticals(美國)
  • CorePharma(美國)
  • Cypress Pharmaceutical(美國)
  • Elite Pharmaceuticals(美國)
  • Epic Pharma(美國)
  • Exela Pharma Sciences(美國)
  • Ferndale Pharma Group(美國)
  • Fougera(美國)
  • G&W Laboratories(美國)
  • GeneraMedix Pharmaceuticals(美國)
  • Greenstone(美國)
  • Handa Pharmaceuticals(美國)
  • Hanford Pharmaceuticals(美國)
  • Harris Pharmaceutical(美國)
  • Heritage Pharmaceuticals(美國)
  • Hi-Tech Pharmacal(美國)
  • IGI Laboratories(美國)
  • Indicus Pharma(美國)
  • InvaGen Pharmaceuticals(美國)
  • Kadmon Pharmaceuticals(美國)
  • KUDCo(美國)
  • KVK-Tech(美國)
  • Lehigh Valley Technologies(美國)
  • Luitpold Pharmaceuticals(美國)
  • Lyne Laboratories(美國)
  • Mallinckrodt(美國)
  • Mikah Pharma(美國)
  • Mikart(美國)
  • Nexgen Pharma(美國)
  • Nexus Pharmaceuticals(美國)
  • Nostrum Pharmaceuticals(美國)
  • Novel Laboratories(美國)
  • Orit Laboratories(美國)
  • Osmotica Pharmaceutical(美國)
  • Pharmaceutical Associates(美國)
  • PharmaForce(美國)
  • Prasco Laboratories(美國)
  • Precision Dose(美國)
  • Roxane Laboratories(美國)
  • Sigmapharm Laboratories(美國)
  • Silarx Pharmaceuticals(美國)
  • SOHM(美國)
  • Spear Pharmaceuticals(美國)
  • Stason Pharmaceuticals(美國)
  • Synerx Pharma(美國)
  • ThePharmaNetwork(美國)
  • Tolmar(美國)
  • Tris Pharma(美國)
  • Upsher-Smith Laboratories(美國)
  • URL Pharma(美國)
  • Vanguard Pharmaceutical(美國)
  • VersaPharm(美國)
  • VistaPharm(美國)
  • Gen Pharmaceuticals(美國)
• 南美
  • Laboratorios Phoenix(阿根廷)
  • Hypermarcas(巴西)
  • LAFEPE(巴西)
  • Moksha8(巴西)

Abstract

Key facts, statistics and insights on 160 medium-sized generic manufacturers based in 35 countries!

Collaboration is the key to growth

In the current economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems.

At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of branded medicines have made moves to increase generic prescribing.

But pressure on health spending is seeing downward pressure on generic prices. With lower margins this is creating pain for generics companies.

SME Generic companies offer focused opportunities

With established markets compromised, where can the industry go? Expansion in the sector has been seen through more partnering, either through outright acquisition to increase market share or through product and marketing licensing. Being bigger and having improved market access is seen as a way of distributing cost and strengthening revenues. While major players such as Teva and Sandoz play an international role, there are a number of established and progressive generic manufacturers worthy of consideration.

Find and assess potential partners and acquisition targets with this report

This new report from Espicom is a key resource for the wide assessment of 160 medium-sized generic companies operating in 35 markets worldwide. The report provides an essential and comprehensive evaluation of each company:

• Location, establishment and full contact details
• Financial information, where available
• Products and/or therapy areas
• Recent strategic alliances

Africa

• EIPICo Egypt
• Hikma Pharmaceuticals Jordan
• Regal Pharmaceuticals Kenya
• Oman Pharmaceutical Products Oman
• Adcock Ingram South Africa
• Cipla Medpro South Africa
• Litha Healthcare South Africa
• Pharma Dynamics South Africa
• Sonke Pharmaceuticals South Africa

Asia

• Beximco Pharmaceuticals Bangladesh
• Aoxing Pharmaceutical China
• Laiyang Jiangbo Pharmaceuticals China
• Rxmidas Pharmaceuticals China
• Zhejiang Huahai Pharmaceuticals China
• Alembic Pharmaceuticals India
• Alkem Laboratories India
• Bafna Pharmaceuticals India
• Bharat Serums and Vaccines India
• Biocon India
• Claris Lifesciences India
• Emcure India
• Gland Pharma India
• Glenmark Pharmaceuticals India
• Granules India India
• Hetero Drugs India
• Indoco Remedies India
• Intas Pharmaceuticals India
• JB Chemicals & Pharmaceuticals India
• Jubilant Life Sciences India
• Macleods Pharmaceuticals India
• Marksans Pharma India
• Micro Labs India
• Natco Pharma India
• Orchid Chemicals & Pharmaceuticals India
• RPG Life Sciences India
• Shasun Pharmaceuticals India
• Strides Arcolab India
• Torrent Pharmaceuticals India
• Unichem Laboratories India
• Venus Remedies India
• Nichi-Iko Pharmaceuticals Japan
• Nippon Chemiphar Japan
• Towa Pharmaceutical Japan
• CCM Pharmaceuticals Malaysia
• Inno Biologics Malaysia
• Pharmaniaga Berhad Malaysia
• ScinoPharm Taiwan Taiwan
• Government Pharmaceutical Organisation Thailand
• Abdi Ibrahim Turkey
• EastPharma Turkey
• Mustafa Nevzat Pharmaceuticals Turkey
• Nanogen Biopharmaceuticals Vietnam

Australasia

• Alchemia Australia
• Ascent Pharmahealth Australia

Europe

• BioAlliance Pharma France
• Alfred E Tiefenbacher Germany
• Genepharm Greece
• Pharmathen Greece
• Consilient Health Ireland
• Reliance GeneMedix Ireland
• ACS Dobfar Italy
• Grindeks Latvia
• Sanitas Lithuania
• Genmed Holdings Netherlands
• Synthon Netherlands
• Navamedic Norway
• Polpharma Poland
• Hovione FarmaCiencia Portugal
• R-Pharm Russia
• Laboratorios Cinfa Spain
• Bluefish Pharmaceuticals Sweden
• Acino Switzerland
• Legacy Pharmaceuticals International Switzerland
• Goldshield Group UK
• Kent Pharmaceuticals UK
• Syntropharma UK

North America

• AA Pharma Canada
• BioVectra Canada
• Intellipharmaceutics International Canada
• Acella Pharmaceuticals USA
• Aceto USA
• Akorn USA
• Altaire Pharmaceuticals USA
• Alvogen USA
• Amerigen Pharmaceuticals USA
• Amneal Pharmaceuticals USA
• Amphastar Pharmaceuticals USA
• Anchen Pharmaceutical USA
• Antares Pharma USA
• Apicore USA
• APP Pharmaceuticals USA
• Austarpharma USA
• Avanthi USA
• Banner Pharmacaps USA
• Bedford Laboratories USA
• Biokey USA
• Boca Pharmacal USA
• Breckenridge Pharmaceutical USA
• Cambrex USA
• Carlsbad Technology USA
• Cephazone Pharma USA
• Cobrek Pharmaceuticals USA
• CorePharma USA
• Cypress Pharmaceutical USA
• Elite Pharmaceuticals USA
• Epic Pharma USA
• Exela Pharma Sciences USA
• Ferndale Pharma Group USA
• Fougera USA
• G&W Laboratories USA
• GeneraMedix Pharmaceuticals USA
• Greenstone USA
• Handa Pharmaceuticals USA
• Hanford Pharmaceuticals USA
• Harris Pharmaceutical USA
• Heritage Pharmaceuticals USA
• Hi-Tech Pharmacal USA
• IGI Laboratories USA
• Indicus Pharma USA
• InvaGen Pharmaceuticals USA
• Kadmon Pharmaceuticals USA
• KUDCo USA
• KVK-Tech USA
• Lehigh Valley Technologies USA
• Luitpold Pharmaceuticals USA
• Lyne Laboratories USA
• Mallinckrodt USA
• Mikah Pharma USA
• Mikart USA
• Nexgen Pharma USA
• Nexus Pharmaceuticals USA
• Nostrum Pharmaceuticals USA
• Novel Laboratories USA
• Orit Laboratories USA
• Osmotica Pharmaceutical USA
• Pharmaceutical Associates USA
• PharmaForce USA
• Prasco Laboratories USA
• Precision Dose USA
• Roxane Laboratories USA
• Sigmapharm Laboratories USA
• Silarx Pharmaceuticals USA
• SOHM USA
• Spear Pharmaceuticals USA
• Stason Pharmaceuticals USA
• Synerx Pharma USA
• ThePharmaNetwork USA
• Tolmar USA
• Tris Pharma USA
• Upsher-Smith Laboratories USA
• URL Pharma USA
• Vanguard Pharmaceutical USA
• VersaPharm USA
• VistaPharm USA
• Gen Pharmaceuticals USA

South America

• Laboratorios Phoenix Argentina
• Hypermarcas Brazil
• LAFEPE Brazil
• Moksha8 Brazil

About the Author:

Generic Drugs: Global Collaboration Opportunities has been researched and written by Espicom editor Ian Platts. In addition to this report, Ian edits the leading newsletter World Generic Markets and has monitored the generics market for over 10 years. Other reports in the series;

AboutEspicom:

Espicom Business Intelligence is a highly-regarded and established provider of business intelligence services. Founded in 1982 as MDIS Publications Ltd, the company changed its name to Espicom in 1997. Initially a publisher in a wide range of industries such as power generation and telecommunications, we now focus on the global pharmaceutical and medical device sectors.

Report Statistics:

• Publication Date: December 2nd 2011
• Total Number of Pages: 410
• Available Formats: Web, PDF and Paper

Table of Contents

Introduction

• Companies in this report
• Company Details in Focus

Argentina

Laboratorios Phoenix

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Australia

Alchemia

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Ascent Pharmahealth

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Bangladesh

Beximco Pharmaceuticals

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Brazil

Hypermarcas

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

LAFEPE

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Moksha8

• Snapshot
• Background
• Products
• Major Developments
• Contact Details
• Canada

AA Pharma

• Snapshot
• Background
• Products
• Contact Details

BioVectra

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Intellipharmaceutics

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

China

Aoxing Pharmaceutical

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

China Pharma Holdings

• Snapshot
• Background
• Products
• Financials
• Contact Details

Laiyang Jiangbo Pharmaceuticals

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Rxmidas Pharmaceuticals

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Zhejiang Huahai Pharmaceuticals

• Snapshot
• Background
• Products
• Contact Details

Egypt

EIPICo

• Snapshot
• Background
• Products
• Contact Details

France

BioAlliance Pharma

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Germany

Alfred E TiefenBacher (AET)

• Snapshot
• Background
• Products
• Contact Details

Greece

Genepharm

• Snapshot
• Background
• Products
• Contact Details

Pharmathen

• Snapshot
• Background
• Products
• Financials
• Contact Details

India

Alembic

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Alkem Laboratories

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Bafna Pharmaceuticals

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Bharat Serums and Vaccines

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Biocon

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Claris Lifesciences

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Emcure

• Snapshot
• Background
• Products
• Contact Details

Gland Pharma

• Snapshot
• Background
• Products
• Contact Details

Glenmark Pharmaceuticals

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Granules India

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Hetero Drugs

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Indoco Remedies

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Intas Pharmaceuticals

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

JB Chemicals & Pharmaceuticals

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Jubilant Life Sciences

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Macleods Pharmaceuticals

• Snapshot
• Background
• Products
• Contact Details

Marksans Pharma

• Snapshot
• Background
• Products
• Financials
• Contact Details

Micro Labs

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Natco Pharma

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Orchid Chemicals & Pharmaceuticals

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

RPG Life Sciences

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Shasun Pharmaceuticals

• Snapshot
• Background
• Products
• Financials
• Contact Details

Strides Arcolab

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Torrent Pharmaceuticals

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Unichem Laboratories

• Snapshot
• Background
• Products
• Financials
• Contact Details

Venus Remedies

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Ireland

Consilient Health

• Snapshot
• Background
• Products
• Contact Details

Reliance GeneMedix

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Italy

ACS Dobfar

• Snapshot
• Background
• Products
• Financials
• Contact Details

Japan

Nichi-Iko Pharmaceutical

• Snapshot
• Background
• Financials
• Major Developments
• Contact Details

Nippon Chemiphar

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Towa Pharmaceutical

• Snapshot
• Background
• Products
• Financials
• Contact Details

Jordan

Hikma Pharmaceuticals

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Kenya

Regal Pharmaceuticals

• Snapshot
• Background
• Products
• Contact Details

Latvia

Grindeks

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Lithuania

Sanitas

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Malaysia

CCM Pharmaceuticals

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Inno Biologics

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Pharmaniaga Berhad

• Snapshot
• Background
• Financials
• Contact Details

Genmed Holding

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Synthon

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Norway

Navamedic

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Oman

Oman Pharmaceutical Products

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Poland

Polpharma

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Portugal

Hovione

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Russia

R-Pharm

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

South Africa

Adcock Ingram

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Cipla Medpro

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Litha Healthcare

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Pharma Dynamics

• Snapshot
• Background
• Products
• Contact Details

Sonke Pharmaceuticals

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Spain

Laboratorios Cinfa

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Sweden

Bluefish Pharmaceuticals

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Switzerland

Acino

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Legacy Pharmaceuticals International

• Snapshot
• Background
• Products
• Contact Details

Taiwan

ScinoPharm Taiwan

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Thailand

Government Pharmaceutical Organisation

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Turkey

Abdi Ibrahim

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

EastPharma

• Snapshot
• Background
• Products
• Financials
• Contact Details

Mustafa Nevzat Pharmaceuticals

• Snapshot
• Background
• Products
• Contact Details

UK

Goldshield

• Snapshot
• Background
• Products
• Contact Details

Kent Pharmaceuticals

• Snapshot
• Background
• Products
• Contact Details

Syntropharma

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

USA

Acella Pharmaceuticals

• Snapshot
• Background
• Products
• Contact Details

Aceto

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Akorn

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Altaire Pharmaceuticals

• Snapshot
• Background
• Products
• Contact Details

Alvogen

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Amerigen Pharmaceuticals

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Amneal Pharmaceuticals

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Amphastar Pharmaceuticals

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Anchen Pharmaceuticals

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Antares Pharma

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Apicore

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

APP Pharmaceuticals

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

AustarPharma

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Avanthi

• Snapshot
• Background
• Products
• Contact Details

Banner Pharmacaps

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Bedford Laboratories

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Biokey

• Snapshot
• Background
• Products
• Contact Details

Boca Pharmacal

• Snapshot
• Background
• Products
• Contact Details

Breckenridge Pharmaceutical

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Cambrex

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Carlsbad Technology

• Snapshot
• Background
• Products
• Contact Details

Cephazone Pharma

• Snapshot
• Background
• Products
• Contact Details

Cobrek Pharmaceuticals

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

CorePharma

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Cypress Pharmaceutical

• Snapshot
• Background
• Products
• Contact Details

Elite Pharmaceuticals

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Epic Pharma

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Exela

• Snapshot
• Background
• Major Developments
• Contact Details

Ferndale Pharma Group

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Fougera

• Snapshot
• Background
• Products
• Contact Details

G&W Laboratories

• Snapshot
• Background
• Products
• Contact Details

GeneraMedix Pharmaceuticals

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Greenstone

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Handa Pharmaceuticals

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Hanford Pharmaceuticals

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Harris Pharmaceutical

• Snapshot
• Background
• Products
• Contact Details

Heritage Pharmaceuticals

• Snapshot
• Background
• Products
• Contact Details

Hi-Tech Pharmacal

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

IGI Laboratories

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Indicus Pharma

• Snapshot
• Background
• Products
• Contact Details

InvaGen Pharmaceuticals

• Snapshot
• Background
• Products
• Contact Details

Kadmon Pharmaceuticals

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

KUDCo

• Snapshot
• Background
• Products
• Contact Details

KVK-Tech

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Lehigh Valley Technologies

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Luitpold Pharmaceuticals

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Lyne Laboratories

• Snapshot
• Background
• Products
• Contact Details

Mallinckrodt

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Mikah Pharma

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Mikart

• Snapshot
• Background
• Products
• Contact Details

Nexgen Pharma

• Snapshot
• Background
• Products
• Contact Details

Nexus Pharmaceuticals

• Snapshot
• Background
• Products
• Contact Details

Nostrum Pharmaceuticals

• Snapshot
• Background
• Products
• Contact Details

Novel Laboratories

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Orit Laboratories

• Snapshot
• Background
• Products
• Contact Details

Osmotica Pharmaceutical

• Snapshot
• Background
• Products
• Contact Details

Pharmaceutical Associates

• Snapshot
• Background
• Products
• Contact Details

PharmaForce

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Prasco Laboratories

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Precision Dose

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Roxane Laboratories

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Sigmapharm Laboratories

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Silarx Pharmaceuticals

• Snapshot
• Background
• Products
• Contact Details

SOHM

• Snapshot
• Background
• Products
• Financials
• Major Developments
• Contact Details

Spear Pharmaceuticals

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Stason Pharmaceuticals

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Synerx Pharma

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

ThePharmaNetwork

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Tolmar

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Tris Pharma

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Upsher-Smith Laboratories

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

URL Pharma

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

Vanguard Pharmaceutical

• Snapshot
• Background
• Products
• Contact Details

VersaPharm

• Snapshot
• Background
• Products
• Contact Details

VistaPharm

• Snapshot
• Background
• Products
• Contact Details

X-GEN Pharmaceutical

• Snapshot
• Background
• Products
• Major Developments
• Contact Details
• Vietnam

Nanogen Biopharmaceutical

• Snapshot
• Background
• Products
• Major Developments
• Contact Details

INDEX OF TABLES

• Companies by country of origin
• Companies' year of establishment, by country
• Companies' year of establishment, by date
• Company employee numbers, by country
• Company employee numbers, by size
• Company financial results, by amount in US$ millions
• Company financial results, by country of origin
• Company financial results, by fiscal year end date
• Alchemia: consolidated fiscal year results, in A$000s
• Alchemia: consolidated fiscal year results, in US$000s
• Ascent Pharmahealth: consolidated fiscal year results in A$000s
• Ascent Pharmahealth: consolidated fiscal year results in US$000s
• Beximco Pharmaceuticals: fiscal year results, in BDT000s
• Beximco Pharmaceuticals: fiscal year results, in US$000s
• Hypermarcas: consolidated fiscal year results, in R$000s
• Hypermarcas: consolidated fiscal year results, in US$000s
• Intellipharmaceutics: consolidated financial results, in US$
• Aoxing Pharmaceutical: consolidated fiscal year results, in US$000s
• China Pharma: consolidated fiscal year results, in US$000s
• Laiyang Jiangbo Pharmaceuticals: financial results, in US$000s
• Huahai US ANDA Approvals, January 2002 - September 2011
• BioAlliance Pharma: fiscal year results, in euro 000s
• BioAlliance Pharma: fiscal year results, in US$000s
• Alembic Pharmaceuticals ANDA approvals, January 2002 - September 2011
• Alkem Laboratories ANDA Approvals, January 2002 - September 2011
• Bafna Pharmaceuticals: fiscal year results, in Rs millions
• Bafna Pharmaceuticals: fiscal year results, in US$ millions
• Biocon: consolidated financial results, in Rs millions
• Biocon: consolidated financial results, in US$ millions
• Claris Lifesciences ANDA Approvals, January 2002 - September 2011
• Claris Lifesciences: consolidated fiscal year results, in Rs millions
• Claris Lifesciences: consolidated fiscal year results, in US$ millions
• Emcure ANDA Approvals, January 2002 - September 2011
• Gland Pharma ANDA Approvals, January 2002 - September 2011
• Glenmark Pharmaceuticals / Glenmark Generics ANDA Approvals, January 2002 - September 2011
• Glenmark Pharmaceuticals: consolidated financial results in Rs millions
• Glenmark Pharmaceuticals: consolidated financial results in US$ millions
• Granules India ANDA Approvals, January 2002 - September 2011
• Granules India: consolidated fiscal year results, in Rs millions
• Granules India: consolidated fiscal year results, in US$ millions
• Hetero Drugs ANDA Approvals, January 2002 - September 2011
• Indoco Remedies: global product registrations, year ended 31st March 2011
• Indoco Remedies: financial results, in Rs millions
• Indoco Remedies: financial results, in US$ millions
• Accord Healthcare ANDA approvals, January 2002 - September 2011
• Intas Pharmaceuticals: fiscal year results in R millions
• Intas Pharmaceuticals: fiscal year results in US$ millions
• Unique Pharmaceutical Laboratories ANDA Approvals, January 2002 - September 2011
• JB Chemicals & Pharmaceuticals: consolidated financial results, in Rs millions
• JB Chemicals & Pharmaceuticals: consolidated financial results, in US$ millions
• Trigen Laboratories / Cadista Pharmaceuticals / Jubilant Pharmaceuticals / Jubilant Life ANDA Approvals, January 2002 - September 2011
• Jubilant Life Sciences: consolidated financial results, in Rs millions
• Jubilant Life Sciences: consolidated financial results, in US$ millions
• Marksans Pharma ANDA Approvals, January 2002 - September 2011
• Marksans Pharma: consolidated financial results, in Rs millions
• Marksans Pharma: financial results, in US$ millions
• Micro Labs ANDA Approvals, January 2002 - September 2011
• Natco Pharma ANDA Approvals, January 2002 - September 2011
• Natco Pharma: consolidated financial results, in Rs millions
• Natco Pharma: consolidated financial results, in US$ millions
• Orchid Healthcare ANDA Approvals, January 2002 - September 2011
• Orchid Chemicals & Pharmaceuticals: consolidated fiscal year results, in Rs millions
• Orchid Chemicals & Pharmaceuticals: consolidated fiscal year results, in US$ millions
• RPG Life Sciences: fiscal year results, in Rs000s
• RPG Life Sciences: fiscal year results, in US$000s
• Shasun USA ANDA Approvals, January 2002 - September 2011
• Shasun Pharmaceuticals: consolidated financial results, in Rs millions
• Shasun Pharmaceuticals: consolidated financial results, in US$ millions
• Strides Arcolab ANDA Approvals, January 2002 - September 2011
• Akorn-Strides ANDA Approvals, January 2002 - September 2011
• Sagent-Strides ANDA Approvals, January 2002 - September 2011
• Strides Arcolab: consolidated financial results, in Rs millions
• Strides Arcolab: consolidated financial results, in US$ millions
• Torrent Pharmaceuticals ANDA Approvals, January 2002 - September 2011
• Torrent Pharmaceuticals: consolidated financial results, in Rs millions
• Torrent Pharmaceuticals: consolidated financial results, in US$ millions
• Unichem Laboratories / Unichem Pharmaceuticals USA ANDA Approvals, January 2002 - September 20111
• Unichem Laboratories: consolidated fiscal year results, in Rs millions
• Unichem Laboratories: consolidated fiscal year results, in US$ millions
• Venus Remedies: consolidated financial year results, in Rs millions
• Venus Remedies: consolidated financial year results, in US$ millions
• Reliance GeneMedix: consolidated financial results, in euro 000s
• Reliance GeneMedix: consolidated financial results, in US$000s
• Dobfar ANDA approvals, January 2002 - September 2011
• Dobfar: fiscal year results, in euro millions
• Dobfar: fiscal year results, in US$ millions
• Nichi-Iko: consolidated financial results, in \ millions
• Nichi-Iko: consolidated financial results, in US$ millions
• Nippon Chemiphar: consolidated financial results, in \ millions
• Nippon Chemiphar: consolidated financial results, in US$ millions
• Towa Pharmaceutical: consolidated financial results, in yen millions
• Towa Pharmaceutical: consolidated financial results, in US$ millions
• Hikma Pharmaceuticals ANDA Approvals, January 2002 - September 2011
• West-Ward ANDA Approvals, January 2002 - September 2011
• Hikma Pharmaceuticals: consolidated financial results, in US$000s
• Grindeks Group: financial results, in LVL000s
• Grindeks Group: financial results, in US$000s
• Sanitas: Group Financial Results, in LTL000s
• Sanitas: Group Financial Results, in US$000s
• CCM: group fiscal year results, in RM000s
• CCM: group fiscal year results, in US$000s
• Pharmaniaga Berhad: group fiscal year results, in RM000s
• Pharmaniaga Berhad: group fiscal year results, in US$000s
• Genmed Holding: consolidated financial results, in US$000s
• Synthon Pharmaceuticals / Synthon Laboratories ANDA Approvals, January 2002 - September 2011
• Navamedic: financial results, in NOK000s
• Navamedic: financial results, in US$000s
• Oman Pharmaceutical Products ANDA Approvals, January 2002 - September 2011
• Pharm: fiscal year results in US$ millions
• Adcock Ingram: consolidated fiscal year results, in R000s
• Adcock Ingram: consolidated fiscal year results, in US$000s
• Cipla Medpro: Group fiscal year results, in R000s
• Cipla Medpro: Group fiscal year results, in US$000s
• Litha Healthcare Group: financial results, in R000s
• Litha Healthcare Group: financial results, in US$000s
• Laboratorios Cinfa: financial results, in euro millions
• Laboratorios Cinfa: financial results, in US$ millions
• Bluefish Pharmaceuticals: consolidated fiscal year results, in SEK000s
• Bluefish Pharmaceuticals: consolidated fiscal year results, in US$000s
• Acino Group: consolidated fiscal year results, in CHF / euro millions
• Acino Group: consolidated fiscal year results, in US$ millions
• Solco Healthcare ANDA approvals, January 2002 - September 2011
• ScinoPharm Taiwan: non-consolidated financial year results, in TWD000s
• ScinoPharm Taiwan: non-consolidated financial year results, in US$000s
• EastPharma: consolidated fiscal year results, in US$000s
• Mustafa Nevzat Pharmaceuticals ANDA Approvals, 2002 - September 2011
• Aceto: fiscal year results, in US$000s
• Akorn ANDA approvals, January 2002 - September 2011
• Akorn-Strides ANDA approvals, January 2002 - September 2011
• Akorn: consolidated fiscal year results, in US$000s
• Altaire Pharmaceuticals ANDA approvals, January 2002 - September 2011
• Amneal Pharmaceuticals ANDA Approvals, January 2002 - September 2011
• Interpharm ANDA Approvals, January 2002 - December 2008
• Amphastar Pharmaceuticals ANDA Approvals, January 2002 - September 2011
• International Medication Systems ANDA Approvals, January 2002 - September 2011
• Anchen Pharmaceuticals ANDA Approvals, January 2002 - September 2011
• Antares Pharma: consolidated fiscal year results, in US$000s
• American Pharmaceutical Partners ANDA Approvals, January 2002 - December 2006
• Abraxis ANDA Approvals, January 2002 - December 2008
• APP Pharmaceuticals ANDA Approvals, January 2008 - September 2011
• AustarPharma ANDA Approvals, January 2009 - September 2011
• Avanthi ANDA Approvals, January 2002 - September 2011
• Banner Pharmacaps ANDA Approvals, January 2002 - September 2011
• Bedford Laboratories ANDA Approvals, January 2002 - September 2011
• Biokey ANDA Approvals, January 2002 - September 2011
• Boca Pharmacal ANDA Approvals, January 2002 - September 2011
• Breckenridge Pharmaceuticals ANDA Approvals, January 2002 - September 2011
• Cambrex: consolidated fiscal year results, in US$000s
• Carlsbad Technology ANDA Approvals, January 2002 - September 2011
• Cephazone Pharma ANDA Approvals, January 2002 - September 2011
• Cobrek Pharmaceuticals ANDA Approvals, January 2002 - September 2011
• CorePharma ANDA Approvals, January 2002 - September 2011
• Cypress Pharmaceutical ANDA Approvals, January 2002 - September 2011
• Elite Pharmaceuticals: consolidated fiscal year results, in US$000s
• Epic Pharma ANDA Approvals, January 2002 - September 2011
• Ferndale Laboratories ANDA Approvals, January 2002 - September 2011
• Altana ANDA Approvals, January 2002 - September 2011
• Nycomed ANDA Approvals, January 2002 - September 2011
• G&W Laboratories ANDA Approvals, January 2002 - September 2011
• GeneraMedix ANDA Approvals, January 2002 - September 2011
• Hanford Manufacturing ANDA Approvals, January 2002 - September 2011
• Hi-Tech Pharmacal ANDA Approvals, January 2002 - September 2011
• Hi-Tech Pharmacal: financial results, in US$000s
• IGI Laboratories: consolidated financial results, in US$000s
• Indicus Pharmaceuticals ANDA Approvals, January 2002 - September 2011
• InvaGen Pharmaceuticals ANDA Approvals, January 2002 - September 2011
• Three Rivers ANDA Approvals, January 2002 - September 2011
• KUDCo ANDA Approvals, January 2002 - September 2011
• KVK-Tech ANDA Approvals, January 2002 - September 2011
• Luitpold Pharmaceuticals ANDA Approvals, January 2002 - September 2011
• Lyne Laboratories ANDA Approvals, January 2002 - September 2011
• Mallinckrodt ANDA Approvals, January 2002 - September 2011
• Mikart ANDA Approvals, January 2002 - September 2011
• Nexgen Pharma / Anabolic Laboratories ANDA Approvals, January 2002 - September 2011
• Nexus Pharmaceuticals ANDA Approvals, January 2002 - September 2011
• Nostrum Pharmaceuticals ANDA Approvals, January 2002 - September 2011
• Novel Laboratories ANDA Approvals, January 2002 - September 2011
• Orit Laboratories ANDA Approvals, January 2002 - September 2011
• Osmotica Pharmaceutical ANDA Approvals, January 2002 - September 2011
• Pharmaceutical Associates ANDA Approvals, January 2002 - September 2011
• PharmaForce ANDA Approvals, January 2002 - September 2011
• Precision Dose ANDA Approvals, January 2002 - September 2011
• Roxane Laboratories ANDA Approvals, January 2002 - September 2011
• Sigmapharm Laboratories ANDA Approvals, January 2002 - September 2011
• Silarx Pharmaceuticals ANDA Approvals, January 2002 - September 2011
• Spear Pharmaceuticals ANDA Approvals, January 2002 - September 2011
• Stason Pharmaceuticals ANDA Approvals, January 2002 - September 2011
• Synerx Pharma ANDA Approvals, January 2004 - September 2011
• ThePharmaNetwork ANDA Approvals, January 2002 - September 2011
• Tolmar ANDA Approvals, January 2002 - September 2011
• Tris Pharma ANDA Approvals, January 2002 - September 2011
• Upsher-Smith Laboratories ANDA Approvals, January 2002 - September 2011
• Mutual Pharmaceutical Company ANDA Approvals, January 2002 - September 2011
• VersaPharm ANDA Approvals, January 2002 - September 2011
• Covenant Pharma ANDA Approvals, January 2002 - September 2011
• VistaPharm ANDA Approvals, January 2002 - September 2011
• X-GEN Pharmaceuticals ANDA Approvals, January 2002 - September 2011